Health System

About 4 in 10 patients with chronic kidney disease will have “early rapid decline,” a trajectory more likely if the patient also has diabetes.

While polypharmacy, along with hospital length of stay and other factors, was linked to a higher risk of 30-day hospital readmission, the type of medication mattered as well.

Many respiratory viruses demonstrated atypical activity levels as compared with previous rates of activity during pre-pandemic seasonality, the CDC said this week.

Anne Marie Morse, DO, pediatric neurologist and sleep medicine specialist, Geisenger, speaks on early data findings of the Wake Up and Learn program which suggested a greater risk of sleep pathology among adolescents than typically observed.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

The federal government requires insurers to cover PrEP; Johnson & Johnson (J&J) and pharmaceutical wholesalers agree to settle opioid crisis lawsuits; NYC health care workers will be required to receive a vaccine or weekly tests for COVID-19.

With the delta variant now dominant in the United States, study results highlight the need for officials to do everything they can to increase vaccine uptake.

The Academy of Sleep Medicine and the Sleep Research Society issued guiding principles for employers on designing optimal work shift durations in the workplace, which address risk factors, countermeasures, and shared decision-making implications.

In this episode of Managed Care Cast, the lead author of an article in the July issue of The American Journal of Managed Care describes the latest research that looks at the power of self-insured employers to negotiate hospital prices and the relationship between employer market power and hospital prices.

CMS proposes rule on price transparency and emergency care access in rural communities and health care gaps exacerbated by the pandemic; wildfire smoke is associated with increased susceptibility to COVID-19; American Academy of Pediatrics recommends mask mandates in schools.

Patients with Parkinson disease treated with acupuncture-related therapies combined with conventional medication exhibited significant improvements in motor function and experiences of daily living, although the quality of findings may warrant future research.

New cases of COVID-19 are rising in all 50 states for the third consecutive day; stark increase in alcohol-associated liver disease hospitalizations reported amid the pandemic; nearly 2 dozen reports of mysterious health incidents have been observed among US personnel in Vienna, Austria.

Michael Thompson, president and chief executive officer of the National Alliance of Healthcare Purchaser Coalitions, speaks on the growth of telehealth and value-based care amid the COVID-19 pandemic, and the influence they will have on care delivery strategies in the years to come.

An overview of the latest news in Parkinson disease reported across MJH Life Sciences™.

Larger primary care practices in downside risk–only payment models and capitation saw the highest telemedicine utilization rates by their patients enrolled in Medicare Advantage (MA) plans.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

Michael Thorpy, MD, director, Sleep-Wake Disorders Center, Montefiore, and professor of neurology, Albert Einstein College of Medicine, addresses the treatment of narcolepsy in recent years.

Highlighting the latest ophthalmology-related news reported across MJH Life Sciences™.

Patients with Parkinson disease who participated in weekly dance training with music exhibited no decline in motor function and motor or nonmotor experiences of daily living across a 3-year span.

The new standards come as community oncology practices await word on the future of the oncology care model, which will expire in 2022.

HHS officials say that fully vaccinated individuals do not need to get a booster shot; FDA issues a warning on link between the Johnson & Johnson vaccine and a rare neurological condition; California counties sue pesticide manufacturer over widely used bug killer that may cause brain damage in children and fetuses.

The development of a successful gene therapy for RPE65-associated inherited retinal disease is a major breakthrough, but it also prompts difficult questions about which patients are good candidates for the therapy.

An overview of the latest news in Parkinson disease reported across MJH Life Sciences™.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

New data underscore how obesity, racial disparities and recent treatment advancements have impacted cancer mortality and incidence rates.